BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 16614251)

  • 21. Improved detection methods by genetic and immunological techniques for botulinum C/D and D/C mosaic neurotoxins.
    Nakamura K; Kohda T; Seto Y; Mukamoto M; Kozaki S
    Vet Microbiol; 2013 Mar; 162(2-4):881-890. PubMed ID: 23206412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of toxin-producing Clostridium botulinum with the macroalga Cladophora in the Great Lakes.
    Chun CL; Ochsner U; Byappanahalli MN; Whitman RL; Tepp WH; Lin G; Johnson EA; Peller J; Sadowsky MJ
    Environ Sci Technol; 2013 Mar; 47(6):2587-94. PubMed ID: 23421373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotoxin gene profiling of clostridium botulinum types C and D native to different countries within Europe.
    Woudstra C; Skarin H; Anniballi F; Fenicia L; Bano L; Drigo I; Koene M; Bäyon-Auboyer MH; Buffereau JP; De Medici D; Fach P
    Appl Environ Microbiol; 2012 May; 78(9):3120-7. PubMed ID: 22344654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of feces and serum for diagnosis of infant botulism in 336 patients.
    Hatheway CL; McCroskey LM
    J Clin Microbiol; 1987 Dec; 25(12):2334-8. PubMed ID: 3323228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan.
    Umeda K; Seto Y; Kohda T; Mukamoto M; Kozaki S
    J Clin Microbiol; 2009 Sep; 47(9):2720-8. PubMed ID: 19571018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of Clostridium botulinum toxin gene expression by competitive reverse transcription-PCR.
    McGrath S; Dooley JS; Haylock RW
    Appl Environ Microbiol; 2000 Apr; 66(4):1423-8. PubMed ID: 10742222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of real-time PCR tests for detecting botulinum neurotoxins A, B, E, F producing Clostridium botulinum, Clostridium baratii and Clostridium butyricum.
    Fach P; Micheau P; Mazuet C; Perelle S; Popoff M
    J Appl Microbiol; 2009 Aug; 107(2):465-73. PubMed ID: 19291235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Clostridium botulinum strains associated with an infant botulism case in the United Kingdom.
    Johnson EA; Tepp WH; Bradshaw M; Gilbert RJ; Cook PE; McIntosh ED
    J Clin Microbiol; 2005 Jun; 43(6):2602-7. PubMed ID: 15956371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum neurotoxins: more and more diverse and fascinating toxic proteins.
    Popoff MR
    J Infect Dis; 2014 Jan; 209(2):168-9. PubMed ID: 24106294
    [No Abstract]   [Full Text] [Related]  

  • 30. Real-time PCR detection of the nontoxic nonhemagglutinin gene as a rapid screening method for bacterial isolates harboring the botulinum neurotoxin (A-G) gene complex.
    Raphael BH; Andreadis JD
    J Microbiol Methods; 2007 Dec; 71(3):343-6. PubMed ID: 17961766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First report of an infant botulism case due to Clostridium botulinum type Af.
    de Jong LI; Fernández RA; Pareja V; Giaroli G; Guidarelli SR; Dykes JK; Lúquez C
    J Clin Microbiol; 2015 Feb; 53(2):740-2. PubMed ID: 25502535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory Networks Controlling Neurotoxin Synthesis in
    Popoff MR; Brüggemann H
    Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737025
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of immunodetection system for botulinum neurotoxin serotype E.
    Sarita R; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Indian J Med Res; 2018 Jun; 147(6):603-610. PubMed ID: 30168493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of PCR to a clinical and environmental investigation of a case of equine botulism.
    Szabo EA; Pemberton JM; Gibson AM; Thomas RJ; Pascoe RR; Desmarchelier PM
    J Clin Microbiol; 1994 Aug; 32(8):1986-91. PubMed ID: 7989554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes.
    Hill KK; Smith TJ
    Curr Top Microbiol Immunol; 2013; 364():1-20. PubMed ID: 23239346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-dimensional nanoscale liquid chromatography and nano-electrospray ion-trap mass spectrometry for detection of Clostridium botulinum type C and the produced botulinum neurotoxin type C complex.
    Plößl T; Vujtovic-Ockenga N; Kehrenberg C; Klaubert B
    J Microbiol Methods; 2022 Feb; 193():106397. PubMed ID: 34952090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal outbreak of botulism in Greenland.
    Hammer TH; Jespersen S; Kanstrup J; Ballegaard VC; Kjerulf A; Gelvan A
    Infect Dis (Lond); 2015 Mar; 47(3):190-4. PubMed ID: 25622940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism.
    McCroskey LM; Hatheway CL; Fenicia L; Pasolini B; Aureli P
    J Clin Microbiol; 1986 Jan; 23(1):201-2. PubMed ID: 3517043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium botulinum in the post-genomic era.
    Peck MW; Stringer SC; Carter AT
    Food Microbiol; 2011 Apr; 28(2):183-91. PubMed ID: 21315972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of high-density DNA resequencing microarray for detection and characterization of botulinum neurotoxin-producing clostridia.
    Vanhomwegen J; Berthet N; Mazuet C; Guigon G; Vallaeys T; Stamboliyska R; Dubois P; Kennedy GC; Cole ST; Caro V; Manuguerra JC; Popoff MR
    PLoS One; 2013; 8(6):e67510. PubMed ID: 23818983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.